Etodolac Tablet, Film Coated
NDC Package 70518-3845-0

11-digit billing NDC: 70518384500

Package Information

Etodolac tablets is carefully consider the potential benefits and risks of etodolac and other treatment options before deciding to use etodolac. This formulation utilizes a tablet, film coated delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-3845 and is authorized under FDA application ANDA076004.

Identification & Billing

NDC Package Code
70518-3845-0
Package Description
60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
70518384500
RxNorm Crosswalk
RxCUI: 199390 - etodolac 500 MG Oral Tablet

Clinical Specifications

Proprietary Name
Etodolac
Non-Proprietary Name
Etodolac
Substance Name
Etodolac
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Carefully consider the potential benefits and risks of etodolac and other treatment options before deciding to use etodolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). Etodolac tablets, USP are indicated:For acute and long-term use in the management of signs and symptoms of the following: OsteoarthritisRheumatoid arthritisFor the management of acute pain

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA076004
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-30-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-3845-0 identifies a specific commercial package of 60 tablet, film coated in 1 bottle, plastic of Etodolac, a human prescription drug labeled by Remedyrepack Inc.. This tablet, film coated is formulated for oral use and contains etodolac as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on August 30, 2023. The current certification is valid through December 31, 2027.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518384500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-3845-0
11-Digit CMS (5-4-2)
70518-3845-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.